Over the past year, the Case Comprehensive Cancer Center has undertaken a program and center-wide effort to identify our scientific initiatives for the next 6 years, and to integrate these with our research programs. This effort engaged the help of our entire membership, guided by our Executive Committee (EC), Institutional Advisory Committee, and External Advisory Committee. The resulting Strategic Plan complements the SOM strategic plan, and looks forward through 2023. It was presented to and reviewed by the NCI site visit panel and was well received.  

 

I ask you to please review the new strategic plan and provide input. It is a roadmap, but is not in concrete: we expect to nuance it over the short term and overhaul it over the long term by responding to new opportunities and discoveries. Remember, the Center will invest in these initiatives. If there is a major need that would benefit from a Cancer Center focus or investment, it is best done through advocacy for its inclusion in the strategic plan and coordination with the research programs.

 

Over the next two months, the EC will identify 2-4 coordinating leaders per new initiative who will be charged with providing depth to the initiative through working groups and presenting their plans to the EC. After which, we will announce new support efforts for these initiatives.

 

I hope you find the strategic plan helpful, and I encourage you to consider it as you move your own initiatives forward. 

 

This event will showcase cutting-edge research, with a focus on reducing and eliminating disparities in cancer, going from bench-to-bedside-to-community and back. This important symposium will also feature two keynote addresses, including a key leader in our community, and an internationally-recognized cancer disparities researcher. We will promote the exchange of ideas and collaborative opportunities among scientists, clinicians, government, and community representatives.

 

CALL FOR ABSTRACTS

We invite abstracts from attendees, organized into two areas: Academic Science and Community. Abstracts must be submitted via email to [email protected] by 5 pm on January 5, 2018. Visit the event website for more information.

The CWRU Barrett's Esophagus Translational Research Network (BETRNet) Research Center, supported by NIH/NCI U54CA163060, announces a program to encourage innovative transdisciplinary and translational research related to Barrett's Esophagus (BE). The overall objectives of the program are: 1) to encourage innovative transdisciplinary and translational research, especially high risk/high impact research; 2) to explore emerging opportunities and to enhance productivity of the research projects in the BETRNet, and; 3) to attract new researchers, resources and technologies to conduct translational research on BE and Esophageal Adenocarcinoma (EAC).  

Limited awards of up to $40,000/year will be made to eligible applicants for one year, with the possibility of a second year of funding based on the success of the pilot. Pilot projects must have a transdisciplinary approach and translational research plan focused on BE and/or EAC in one of the focus areas defined by BETRNet.